|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.12 USD | -0.22% |
|
-2.36% | -18.86% |
| Apr. 12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
| Apr. 12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
Theravance Biopharma, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 57.42 million compared to USD 51.35 million a year ago. Net loss was USD 55.19 million compared to net income of USD 872.13 million a year ago.
Basic loss per share from continuing operations was USD 1 compared to USD 1.26 a year ago. Basic loss per share was USD 1 compared to basic earnings per share of USD 11.85 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.86% | 443M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
THERAVANCE BIOPHARMA, INC. 
